NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Insurance broker Marsh reported a rise in fourth-quarter profit on Thursday, helped by robust performance in its risk and insurance services business.Read More